Physician profile
Daniel Worrell
NPI 1043674856
$2,448.35
in general payments reported to CMS, 2019-2025
13 companies · $263 in 2025
The $263 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.59 · 2021: $638 · 2022: $1,011 · 2023: $354 · 2024: $165 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $782.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $781.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,136.12 | 2021-2025 | Mako, Gamma, T2 Alpha |
| Depuy Synthes Sales INC. | $584.34 | 2021-2025 | Va-Lcp, Unium, Na |
| Acumed LLC | $259.09 | 2021-2022 | |
| Si-Bone, INC. | $139.91 | 2022 | |
| Gemini Mountain Medical, LLC | $104.47 | 2022 | |
| Bioventus LLC | $48.88 | 2021-2024 | Exogen Ultrasound Bone Healing System |
| Skeletal Dynamics INC | $48.69 | 2024 | Align, Implate, Ijs |
| Anika Therapeutics, INC. | $35.58 | 2023 | Ovomotion, Tactoset, X-Twist |
| Convatec INC. | $24.93 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $18.44 | 2022 | |
| Rock Medical Orthopedics, INC. | $17.59 | 2019 | |
| Smith+Nephew, INC. | $16.01 | 2022 | |
| Endo Pharmaceuticals INC. | $14.30 | 2023 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Worrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.